Skip to main content
. 2024 Oct 15;16(10):4064–4079. doi: 10.4251/wjgo.v16.i10.4064

Figure 3.

Figure 3

Targeting effector cells with bispecific antibodies for cancer therapy. NK: Natural killer; EPCAM: Epithelial cell adhesion molecule; PSMA: Prostate-specific membrane antigen; BCMA: Bulbospinal muscular atrophy.